Zobrazeno 1 - 10
of 58
pro vyhledávání: '"the WHO 2030 elimination goals"'
Autor:
Maticic, Mojca1,2 (AUTHOR) prof.maticic@gmail.com, Cernosa, J.2 (AUTHOR), Loboda, C.2 (AUTHOR), Tamse, J.2 (AUTHOR), Rigoni, R.3 (AUTHOR), Duffell, E.4 (AUTHOR), Indave, I.5 (AUTHOR), Zimmermann, R.6 (AUTHOR), Darragh, L.3 (AUTHOR), Moura, J.3 (AUTHOR), Leicht, A.7 (AUTHOR), Windelinckx, T.8 (AUTHOR), Jauffret-Roustide, M.9 (AUTHOR), Schiffer, K.3 (AUTHOR), Tammi, T.10 (AUTHOR)
Publikováno v:
Harm Reduction Journal. 11/20/2024, Vol. 21 Issue 1, p1-18. 18p.
Autor:
Mojca Maticic, J. Cernosa, C. Loboda, J. Tamse, R. Rigoni, E. Duffell, I. Indave, R. Zimmermann, L. Darragh, J. Moura, A. Leicht, T. Windelinckx, M. Jauffret-Roustide, K. Schiffer, T. Tammi
Publikováno v:
Harm Reduction Journal, Vol 21, Iss 1, Pp 1-18 (2024)
Abstract Background With the advent of direct acting antivirals (DAAs) the World Health Organisation (WHO) adopted global strategy to eliminate hepatitis C virus (HCV) infection by 2030. In Europe, people who inject drugs (PWID) account for the major
Externí odkaz:
https://doaj.org/article/2d9b7334dabe478397069fae94694153
Autor:
M. Maticic, Z. Pirnat, A. Leicht, R. Zimmermann, T. Windelinck, M. Jauffret-Roustide, E. Duffell, T. Tammi, E. Schatz
Publikováno v:
Harm Reduction Journal, Vol 17, Iss 1, Pp 1-12 (2020)
Abstract Background People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs
Externí odkaz:
https://doaj.org/article/a44321c762f54bedb518fc87445d547f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. Tammi, Mojca Maticic, Ruth Zimmermann, Z. Pirnat, A. Leicht, Eberhard Schatz, Marie Jauffret-Roustide, Erika Duffell, T. Windelinck
Publikováno v:
Harm Reduction Journal
Harm Reduction Journal, BioMed Central, 2020, 17 (1), pp.89. ⟨10.1186/s12954-020-00439-3⟩
Harm Reduction Journal, Vol 17, Iss 1, Pp 1-12 (2020)
Harm Reduction Journal, BioMed Central, 2020, 17 (1), pp.89. ⟨10.1186/s12954-020-00439-3⟩
Harm Reduction Journal, Vol 17, Iss 1, Pp 1-12 (2020)
Background People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the Wor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0350a7c095d2f584f384237571f9692c
https://doi.org/10.1186/s12954-020-00439-3
https://doi.org/10.1186/s12954-020-00439-3
Autor:
M Maticic, Z Pirnat, A Leicht, R Zimmermann, T Windelinckx, M Jauffret-Roustide, E Duffell, T Tammi, E Schatz
BackgroundPeople who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe, however HCV testing and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55e58f9a75d0b4a3156e1dc12021791f
https://doi.org/10.21203/rs.3.rs-87395/v1
https://doi.org/10.21203/rs.3.rs-87395/v1
Autor:
Popping, Stephanie, Verwijs, R, Cuypers, L, Claassen, Mark, van den Berk, GE, De Weggheleire, A, Arends, JEA, Boerekamps, Anne, Molenkamp, Richard, Koopmans, Marion, Verbon, Annelies, Boucher, Charles, Rijnders, Bart, Vijver, David, Lauw, F, Posthouwer, D, Hullegie, S, Bierman, W, Dofferhof, A, Kootstra, GJ, Leyten, E, Hollander, Jessica, van Kasteren, M, Soutekouw, R, Ammerlaan, H, Florence, E
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 71(8), E215-E217. Oxford University Press
Clinical Infectious Diseases, 71(8), E215-E217. Oxford University Press
The transmission of direct-acting antiviral resistance-associated substitutions (RAS) could hamper hepatitis C virus (HCV) cure rates and elimination efforts. A phylogenetic analysis of 87 men who have sex with men recently infected with HCV genotype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6daaef0cbc11e409346fdd4f69536859
https://lirias.kuleuven.be/handle/20.500.12942/707615
https://lirias.kuleuven.be/handle/20.500.12942/707615
Autor:
Baiano, Cassandra X.1 (AUTHOR) cbaiano@dundee.ac.uk, Caven, Madeleine2 (AUTHOR), Robinson, Emma M.2,3 (AUTHOR), Dillon, John F.2,3 (AUTHOR)
Publikováno v:
Journal of Viral Hepatitis. Jun2021, Vol. 28 Issue 6, p909-915. 7p.
Autor:
Anwar, Ilhame1 (AUTHOR) ilhame.anwar@inserm.fr, Donadille, Cécile1 (AUTHOR), Protopopescu, Camelia1 (AUTHOR), Michels, David2,3 (AUTHOR), Herin, Joris4 (AUTHOR), Pladys, Adélaïde5 (AUTHOR), Bader, Danièle5 (AUTHOR), Carrieri, Patrizia1 (AUTHOR), Roux, Perrine1 (AUTHOR)
Publikováno v:
Harm Reduction Journal. 9/21/2023, Vol. 20 Issue 1, p1-9. 9p.
Autor:
Ilhame, Anwar1 (AUTHOR) ilhame.anwar@inserm.fr, Cécile, Donadille1 (AUTHOR), Camelia, Protopopescu1 (AUTHOR), David, Michels2,3 (AUTHOR), Joris, Herin4 (AUTHOR), Adélaïde, Pladys5 (AUTHOR), Danièle, Bader5 (AUTHOR), Patrizia, Carrieri1 (AUTHOR), Perrine, Roux1 (AUTHOR)
Publikováno v:
Harm Reduction Journal. 7/29/2023, Vol. 20 Issue 1, p1-9. 9p.